ArticleFrontiers in medicine2024

Case report: Neoadjuvant-intent pembrolizumab resulted in complete response in a xeroderma pigmentosum patient with locally advanced resectable cutaneous squamous cell carcinoma of the nose.

Nader G Zalaquett et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.